Stephanie Dougan

Dana-Farber Cancer Inst

$3,590,414

Attributed

$6,321,241

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY2021–25

$2M$1.5M$1M$500K$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$6,321,241 · 2

By mechanism

U01$4,096,241 · 1

R01$2,225,000 · 1

Top collaborators

Andrew James Aguirre4 shared
William C Hahn4 shared

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Piotr Sicinski$42,703,610
Gary G Bennett$17,084,880
Donald W. Kufe$50,160,456
Pratiti Bandopadhayay$2,988,759
Neil J. Ganem$5,087,349

Others in their field

Other Emerging Leaders on “Heterogeneity”

Chanza Baytop · Westat, Inc.$271,217,917
Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
Christopher Barnaby Nelson · University Of Melbourne$27,954,628
Kathleen Maletic Neuzil · Emory University$26,258,144
George Robert Painter · University Of Alabama At Birmingham$25,957,440
Jennifer Marie Suga · Kaiser Foundation Research Institute$21,704,579

Research focus

HeterogeneityCellsNeoplastic CellGene ExpressionAffectClinical TrialsCytokineMalignant NeoplasmsTumorSamplingResponsePharmaceutical PreparationsSingle-Cell Rna SequencingProteinsAchievementBinding SitesCell Cycle RegulationBindingAffinityCancer ImmunotherapyCell DivisionBreast Cancer PatientBreast Cancer TreatmentBlood Treatment